RedMedEd

@lymphoma Click on the link below to view catalog and earn CME education.redmeded.com/s/catalog

Presented by lymphoma experts and featuring patient cases, @lymphoma Lymphoma Rounds Symposium series provides information on new therapies and strategies for lymphoma care. Each activity in this series explores an issue central to lymphoma management.

@SurbhiSidanaMD Access case 1 here: tinyurl.com/RRMMATC1 and case 2 here: tinyurl.com/RRMMATC2

Quick, case-based myeloma CME—available now. Make sure your approach to relapsed myeloma is keeping pace with recent advances in our newest Ace the Case activities with @SurbhiSidanaMD #mmsm

How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer? Continuing education from experts @ERPlimackMD @siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care. @RedMedEd

⚠️ CDC estimates that nearly 500,000 American suffer from Alpha-gal syndrome, with emerging evidence suggesting that number is potentially in the millions. “We intend to bring the same urgency, innovation, and scientific rigor to Alpha-gal syndrome that we are to Lyme disease.” —@SecKennedy

@VincentRK This is what happens with the work all the folks here have done

Think you’re up to date on the AEs associated with bladder cancer immunotherapy? Find out in this game-based CME activity developed for APPs, nurses, and other HCPs who treat bladder cancer. @RedMedEd

31% of patients needed to travel by air to be diagnosed with amyloid. ⁦@SLentzsch⁩ sharing key lessons for all doctors to have their clinical hats on to avoid missing this diagnosis ! #mmsm

Did you know that immune checkpoint inhibitors have become a key option for muscle-invasive bladder cancer and locally advanced/metastatic bladder cancer? This @RedMedEd CME activity covers emerging immunotherapies (and how to use them) and other important advances in BC management.

@RedMedEd Find out more: bit.pulse.ly/i8wqhbsnvs

From new immunotherapies to AE management, this game-based CME activity from tests your bladder cancer care acumen while presenting essential information to help keep your practice current and your patients thriving. @RedMedEd

🙌

Med oncs, urologists, APPs, onc nurses: if you see bladder cancer (BC) patients, don’t miss this CME Clinical Callout activity with @RedMedEd

Keep pace with relapsed/refractory myeloma care and earn on-the-go CME with @theMMRF and @HJChoMDPhD1. Designed with a slick, streamlined interface optimized for mobile devices, this activity covers a number of key topics. Earn your credit today: tinyurl.com/RRMMRMEx #mmsm

With @BladderCancerUS and @ERPlimackMD our CME-accredited Clinical Callout activity puts your bladder cancer (BC) care acumen to the test while reviewing the latest developments in BC management. Don’t miss out: tinyurl.com/BCCCRME

Expiring soon: CME on bladder cancer guidelines and emerging immunotherapies. To learn more, visit tinyurl.com/CEminRME Don’t delay: this activity expires on February 21 @ERPlimackMD @BladderCancerUS

Wow!!! #ASH2025

Ready, set… hunt! 👀 Join the first-ever #ASHScavengerHunt at #ASH25! Explore, snap, and share your experience at the 2025 ASH Annual Meeting and Exposition. Register now: bit.ly/3K7pgo3

Looking for CME with challenging bladder cancer cases? Try our online, interactive Clinical Callout on emerging options for bladder cancer care: tinyurl.com/BCCCRME with @ERPlimackMD and @BladderCancerUS